Regeneron Pharmaceuticals | Créanciers Commerciaux



Trade Creditors Changement Date
AbbVie 2.94B 2.66B 2024-12
Agios Pharmaceuticals USD 17.53M 3.81M 2025-06
Alnylam Pharmaceuticals USD 102.39M 4.99M 2025-06
Amgen USD 18.03B 15.63B 2025-06
Astellas Pharma JPY 165.89B 21.95B 2025-06
AstraZeneca 23.99B 1.44B 2025-06
Biogen USD 408.4M 16.9M 2025-06
BioMarin Pharmaceutical 684.25M 390.5M 2025-06
Bristol-Myers Squibb USD 5.43B 1.42B 2025-06
Eli Lilly USD 4.08B 633.7M 2025-06
Gilead Sciences USD 582M 155M 2025-06
GlaxoSmithKline 14.82B 329M 2025-06
Incyte USD 1.41B 1.21B 2025-06
Ionis Pharmaceuticals USD 22.8M 5.34M 2025-06
J&J USD 9.54B 766M 2025-03
Kyowa Hakko Kirin JPY 108.73B 10.35B 2025-06
Merck USD 4.04B 261M 2025-06
Moderna USD 175M 51M 2025-06
Neurocrine Biosciences 104.6M 5.4M 2025-06
Novartis USD 4.51B 245M 2025-06
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.17B 74M 2025-06
Regeneron Pharmaceuticals USD 723.9M 18.4M 2025-06
Roche Holding 4.35B 828M 2024-12
Sanofi 7.55B 118M 2024-12
Sarepta Therapeutics USD 136.7M 19.4M 2025-06
Teva Pharmaceutical Industries USD 2.5B 208M 2025-06
Ultragenyx Pharmaceutical USD 34.24M 13.21M 2025-06
United Therapeutics 432M 426M 2025-06
Vertex Pharmaceuticals USD 3.71B 3.27B 2025-06


Regeneron Pharmaceuticals Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.